We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety and Immunogenicity of New Malaria Vaccine Candidate ChAd63 CS Administered Alone and With MVA CS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01450280
Recruitment Status : Completed
First Posted : October 12, 2011
Last Update Posted : November 29, 2012
Information provided by (Responsible Party):
University of Oxford

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2012
  Study Completion Date : October 2012